Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
Li, Z.; Guo, J.-R.; Chen, Q.-Q.; Wang, C.-Y.; Zhang, W.-J.; Yao, M.-C.; Zhang, W. Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells. Molecules 2017, 22, 499. https://doi.org/10.3390/molecules22030499
Li Z, Guo J-R, Chen Q-Q, Wang C-Y, Zhang W-J, Yao M-C, Zhang W. Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells. Molecules. 2017; 22(3):499. https://doi.org/10.3390/molecules22030499
Chicago/Turabian StyleLi, Zheng, Jian-Ru Guo, Qian-Qian Chen, Cai-Yun Wang, Wei-Jia Zhang, Mei-Cun Yao, and Wei Zhang. 2017. "Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells" Molecules 22, no. 3: 499. https://doi.org/10.3390/molecules22030499


